12:00 AM
 | 
May 24, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

DUSA regulatory update

For administrative reasons, the FDA's Dermatology Advisory Panel will reschedule from June...

Read the full 38 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >